Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.

The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

Trump has previously announced deals to lower costs for Medicaid and direct-to-consumer sales on drugs from Pfizer and ...

Dr Reddy's Labs may face an 8-12 month delay in launching its semaglutide generic in Canada after receiving a non-compliance ...

As Ozempic and other drugs used for weight loss continue to soar in popularity, the U.S. Food and Drug Administration (FDA) has issued a new warning for consumers. On Thursday, the FDA announced it ...